Trial results will tell the full story. Well actually only half the story because it’s an open-label trial, that is not randomised and not blind.
I like your optimism but to say that the trial must be going great guns because it’s still going is a stretch.
The usual suspects were saying the exact same thing about DEP-Docetaxel for 5 long years after it was originally due to finish in 2018. Look how that turned out.
Same theme for DEP-Cabazitaxel.
Yet here we are at 13 cents. The market has spoken.
- Forums
- ASX - By Stock
- SPL
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
0.001(0.54%) |
Mkt cap ! $38.81M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 9.3¢ | $18.55K | 199.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 360670 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 57000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 360670 | 0.093 |
1 | 500000 | 0.092 |
1 | 50000 | 0.091 |
1 | 10331 | 0.090 |
5 | 149337 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 57000 | 3 |
0.096 | 100000 | 1 |
0.097 | 40000 | 1 |
0.098 | 200000 | 1 |
0.100 | 116000 | 4 |
Last trade - 12.40pm 13/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |